In May 2014, the CPGR will boost its Genomics offering with the addition of four high-end next-generation sequencing instruments.
The organisation’s enhanced capacity will comprise of 1 MiSeq (Illumina), 2 Ion Torrent PGMs (Life Technologies) and 1 Ion Proton (Life Technologies).
We will employ a blend of sequencing technologies to offer the best possible support to small- and medium-sized projects with a diverse range of sequencing applications.
In addition to the increasing demand for NGS in bio-medical and agri-biological research, we plan to address a growing interest in clinical applications. For that reasons we are going to dedicate NGS capacity to providing molecular diagnostic applications.
